Recently, the global dispute over standard essential patent (SEP) licensing has escalated once again. The Local Division Mannheim of the UPC and a German court have issued an injunction to prohibit Geely from filing global interim license applications with Hangzhou Intermediate People’s Court, the a

Ⅰ Chinas Innovative Drug "10-Billion-Yuan Club" officially announced with 5 pharmaceutical companies’ breakthroughIn 2025, five companies—BeOne Medicines, Hengrui Pharma, Sino Biopharma, Hansoh Pharma, and Innovent Biologics—became the first to cross the annual revenue threshold of 10 billion yuan f

Recently, the Beijing Intellectual Property Court issued a first-instance judgment dismissing the lawsuit filed by South Koreas LG Chem, Ltd. (hereinafter referred to as "LG Chem") concerning two administrative disputes over the invalidation of its Chinese invention patents. The court rejected LG Ch

Based on the Technology Board 2025 Report (previously known as the Patent Index) released by the European Patent Office (EPO) on March 24, the EPO received 22,031 patent applications from China in 2025, an increase of 9.7% year-on-year. Chinas total number of patent applications rose to 3rd place fo

On the evening of March 12th, Hytera (002583.SZ) released an update on a significant legal case, disclosing that the U.S. District Court for the Northern District of Illinois had issued a final judgment in the criminal trade secrets litigation between the company and the U.S. Department of Justice (